Chen-Xi Zheng

Dr. Chen-Xi Zheng


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 April 2025 in Trends in Cell Biology
Verified
Journal Article
Closed access
SZSha Zhang
Sha Zhang
ZZZong-Yu Zhang
Zong-Yu Zhang
BSBing-Dong Sui
Bing-Dong Sui
CZChen-Xi Zheng
Chen-Xi Zheng
YFYu Fu
Yu Fu

24 July 2025 in International Journal of Oral Science
Verified
Journal Article
Open access
PDF file
JLJianing Liu
Jianing Liu
JHJunxi He
Junxi He
ZZZiqi Zhang
Ziqi Zhang
LLLu Liu
Lu Liu
YCYuan Cao
Yuan Cao
FJFang Jin
Fang Jin
Periodontal bone defects, primarily caused by periodontitis, are highly prevalent in clinical settings and manifest as bone fenestration, dehiscence, or attachment loss, presenting a significant challenge to oral health. In regenerative medicine, harnessing developmental principles for tissue repair offers promising therapeutic potential. Of particular interest is the condensation of progenitor cells, an essential event in organogenesis that has inspired clinically effective cell aggregation approaches in dental regeneration. However, the precise cellular coordination mechanisms during condensation and regeneration remain elusive. Here, taking the tooth as a model organ, we employed single-cell RNA sequencing to dissect the cellular composition and heterogeneity of human dental follicle and dental papilla, revealing a distinct Platelet-derived growth factor receptor alpha (PDGFRA) mesenchymal stem/stromal cell (MSC) population with remarkable odontogenic potential. Interestingly, a reciprocal paracrine interaction between PDGFRA+ dental follicle stem cells (DFSCs) and CD31+ Endomucin+ endothelial cells (ECs) was mediated by Vascular endothelial growth factor A (VEGFA) and Platelet-derived growth factor subunit BB (PDGFBB). This crosstalk not only maintains the functionality of PDGFRA+ DFSCs but also drives specialized angiogenesis. In vivo periodontal bone regeneration experiments further reveal that communication between PDGFRA+ DFSC aggregates and recipient ECs is essential for effective angiogenic-osteogenic coupling and rapid tissue repair. Collectively, our results unravel the importance of MSC-EC crosstalk mediated by the VEGFA and PDGFBB-PDGFRA reciprocal signaling in orchestrating angiogenesis and osteogenesis. These findings not only establish a framework for deciphering and promoting periodontal bone regeneration in potential clinical applications but also offer insights for future therapeutic strategies in dental or broader regenerative medicine.

30 August 2024 in Journal of Nanobiotechnology
Verified
Journal Article
Open access
PDF file
SYSi-Qi Ying
Si-Qi Ying
YCYuan Cao
Yuan Cao
ZZZe-Kai Zhou
Ze-Kai Zhou
XLXin-Yan Luo
Xin-Yan Luo
XZXiao-Hui Zhang
Xiao-Hui Zhang
BSBing-Dong Sui
Bing-Dong Sui
Tissue-derived extracellular vesicles (EVs) are emerging as pivotal players to maintain organ homeostasis, which show promise as a next-generation candidate for medical use with extensive source. However, the detailed function and therapeutic potential of tissue EVs remain insufficiently studied. Here, through bulk and single-cell RNA sequencing analyses combined with ultrastructural tissue examinations, we first reveal that in situ liver tissue EVs (LT-EVs) contribute to the intricate liver regenerative process after partial hepatectomy (PHx), and that hepatocytes are the primary source of tissue EVs in the regenerating liver. Nanoscale and proteomic profiling further identify that the hepatocyte-specific tissue EVs (Hep-EVs) are strengthened to release with carrying proliferative messages after PHx. Moreover, targeted inhibition of Hep-EV release via AAV-shRab27a in vivo confirms that Hep-EVs are required to orchestrate liver regeneration. Mechanistically, Hep-EVs from the regenerating liver reciprocally stimulate hepatocyte proliferation by promoting cell cycle progression through Cyclin-dependent kinase 1 (Cdk1) activity. Notably, supplementing with Hep-EVs from the regenerating liver demonstrates translational potential and ameliorates insufficient liver regeneration. This study provides a functional and mechanistic framework showing that the release of regenerative Hep-EVs governs rapid liver regeneration, thereby enriching our understanding of physiological and endogenous tissue EVs in organ regeneration and therapy.

30 August 2024 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
JLJin‐Yu Liu
Jin‐Yu Liu
JLJie‐Xi Liu
Jie‐Xi Liu
RLRang Li
Rang Li
ZZZi‐Qi Zhang
Zi‐Qi Zhang
XZXiao‐Hui Zhang
Xiao‐Hui Zhang
CZChen-Xi Zheng
Chen-Xi Zheng

25 August 2025 in Exploration
Verified
Journal Article
Open access
SZSha Zhang
Sha Zhang
KZKai Zhang
Kai Zhang
CZChen-Xi Zheng
Chen-Xi Zheng
YGYing‐Feng Gao
Ying‐Feng Gao
GDGuo‐Rong Deng
Guo‐Rong Deng
BSBing-Dong Sui
Bing-Dong Sui
Type 2 diabetes (T2D) is a prevalent metabolic disease inducing alterations of multiple organ systems with currently no cure. Extracellular vesicles (EVs) have been increasingly noticed as one critical paracrine communicator inducing insulin resistance and metabolic disorders in T2D, but clinically available pharmaceuticals for controlling pathological EV release is lacking. Here, we discover that the natural monosaccharide D‐mannose exists with an altered level in the db/db mouse T2D model. Intriguingly, oral administration of D‐mannose with the drinking water safely ameliorates diabetic symptoms in db/db mice. D‐mannose administration does not critically regulate the gut microbiome and circulatory T lymphocytes in treating T2D, while administrated D‐mannose rapidly accumulates in the liver, alleviates hepatic steatosis and rescues insulin resistance. Regarding the mechanism, the T2D pathological EVs released by macrophages are targeted and reduced by D‐mannose, which metabolically inhibits CD36 expression and restores function of hepatocytes. Importantly, by regulating macrophage EV release, D‐mannose administration reveals extra‐hepatic benefits and retards diabetic bone loss. Taken together, our findings unveil D‐mannose as a candidate T2D therapeutic and highlight sugars governing intercellular EV crosstalk, paving an avenue for pharmaceutical T2D approaches with amelioration of multi‐organ deteriorations.

9 June 2024 in Life Sciences
Verified
Journal Article
Closed access
XLXin-Yan Luo
Xin-Yan Luo
SYSi-Qi Ying
Si-Qi Ying
YCYuan Cao
Yuan Cao
YJYan Jin
Yan Jin
FJFang Jin
Fang Jin
BSBing-Dong Sui
Bing-Dong Sui